Sign in
CompletedPhase 2

Sleep Management And Recovery After Traumatic Brain Injury in Kids: Pilot Intervention of Melatonin

Key facts

Who runs it
Oregon Health and Science University
Where
Portland, United StatesSee the site
Trial code
Status
Completed
Phase
Phase 2
People taking part
21 people enrolled
Started
2 Jan 2023
Ended
1 Mar 2025
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • melatonin
  • placebo
Record updated
20 August 2025

Who can take part

Age
6 years to 18 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Other criteria

  • Inclusion:
  • Children age ≥6 years and <19 years
  • Traumatic brain injury defined as disruption of the normal function of the brain resulting from blunt force injury with a severity defined as mild complicated, moderate, or severe by the Glasgow Coma Scale with the presence of intracranial injury on imaging
  • Admission to Oregon Health \& Science University Hospitals
  • Deemed likely to survive hospitalization by clinical care team
  • Able to tolerate enteral medications within 72 hours of admission
  • Child participant resides with parent or legal guardian; Exclusion:
  • Lack stable means of communication with study team (phone, email, mailing address)
  • Abusive trauma suspected or confirmed
  • Dialysis
  • Extracorporeal support (e.g. ECMO)
  • Significant liver injury defined as >2x normal levels for AST or ALT
  • Clinical team safety concerns with use of intervention
  • Pregnancy
  • Prisoners

Where in United States

  • Oregon Health Science UniversityPortland, United States

About the trial

What the trial wants to find out

Sleep wake disturbances compound recovery in over half of pediatric traumatic brain injury survivors, leading to impaired quality of life, and few effective interventions exist to treat this important morbidity. Therefore, this study will conduct a randomized controlled trial evaluating a melatonin intervention started during hospitalization and continued after discharge compared to placebo. The trial will investigate if this intervention is feasible, acceptable, and effective at reducing sleep wake disturbances as measured on the Sleep Disturbances Scale for Children 1-month after hospital discharge.

Read full original descriptionShow less

Participants will be randomly assigned to receive the intervention (melatonin) or to the control group (placebo) with a goal of equal numbers of participants in each group and all will receive sleep education. Participants will be followed closely after consent and outcomes will be assessed at hospital discharge, and 1-month. Outcomes will focus on feasibility (ability to recruit patients into the trial) and acceptability (patient safety and satisfaction), but will also assess the effectiveness of the intervention to reduce sleep disturbances after discharge. The investigators will assess sleep using questionnaires and actigraphy (watch-like activity monitors). Exploratory outcomes will include global health outcomes.

The 2 groups in the trial

  • MelatoninTreatment being tested

    (melatonin doses of 3mg or 5mg based on patient size given nightly 1 hour prior to bedtime every night for 30 days)

  • PlaceboPlacebo, for comparison

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Sleep Management And Recovery After Traumatic Brain Injury in Kids (SMARTKids): Evidence for Targeting Sleep to Improve Outcomes
Record updated
20 August 2025